Global Conference 2011

When it comes to medicine, what was once science fiction is now becoming science. We've moved from mapping the human genome to creating the first synthetic cell. Scientists are developing artificial ovaries that could one day nurture immature human eggs outside the body. Experts in regenerative medicine are printing layers of cells on inkjet printers to construct human organs. The field of nanotechnology is fundamentally changing disease by bringing diagnosis and treatment to the molecular level. And great progress is being made in eradicating diseases that exist in the developing world but have been eliminated in the West. What else is on the horizon for medical science? Will personalized medicine, which rejects one-size-fits-all treatments, fulfill its promise to tailor medical treatments to individuals? Will getting your personal genome reading be as routine as checking your blood pressure? What game-changing drugs for treating cancer, hepatitis and multiple sclerosis seem poised for discovery?


Michael Milken

Chairman, Milken Institute


Elizabeth Blackburn

Nobel Laureate, 2009; Morris Herzstein Professor of Biology and Physiology, Department of Biochemistry and Biophysics, UCSF

Susan Desmond-Hellmann

Chancellor and Arthur and Toni Rembe Rock Distinguished Professor, UCSF

Sean Harper

Global Development and Corporate Chief Medical Officer, Amgen

James Watson

Nobel Laureate, 1962; Chancellor Emeritus, Cold Spring Harbor Laboratory

Return to Program Detail